Aclarion

Yahoo Finance • 29 days ago

Aclarion to Participate in the 38th Annual ROTH Conference, Highlighting Key 2026 Catalysts and Strong Balance Sheet

BROOMFIELD, Colo., March 17, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intellige... Full story

Yahoo Finance • last month

Aclarion CEO Brent Ness to Attend LSI USA 2026

BROOMFIELD, Colo., March 12, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intellige... Full story

Yahoo Finance • 5 months ago

Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion

Marks Aclarion’s first commercial sales hire with seasoned HealthTech leader and proven track record of advancing musculoskeletal imaging and spinal surgeryExperiencing strong commercial traction in UK as first market worldwide with privat... Full story

Yahoo Finance • 6 months ago

Aclarion Wins “Rising Star” at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH

Company previously announced it was selected as a finalist from more than 1,800 submissions Award win underscores growing impact of Aclarion’s breakthrough Nociscan solution for chronic low back pain BROOMFIELD, Colo., Oct. 22, 2025 (G... Full story

Yahoo Finance • 6 months ago

Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst

Debt-free balance sheet with $13.3 million in cash as of today ($15.11 per share fully diluted) providing strategic flexibility for continued commercial growth Nociscan scan volumes increase +89% year-over-year with third consecutive quar... Full story

Yahoo Finance • 6 months ago

Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference

Panel discussion featured at the International Society of Pain and Neuroscience (ISPN) Annual Meeting in London titled United to Conquer Pain Session Co-Moderator Doug Beall, M.D. underscored that disc chemistry is the critical biomarker... Full story

Yahoo Finance • 6 months ago

Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH

BROOMFIELD, Colo., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithm... Full story

Yahoo Finance • 6 months ago

Aclarion Presents at LSI Europe ’25 Highlighting Nociscan Technology and Key Value Drivers

BROOMFIELD, Colo., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithm... Full story

Yahoo Finance • 7 months ago

First Patients Enrolled at UHealth – University of Miami in Aclarion’s Pivotal CLARITY Trial

Enrollment remains on track with internal interim results expected in Q2 2026Randomized study to evaluate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan aims to become the gold standard in identifying so... Full story

Yahoo Finance • 7 months ago

Aclarion Appoints Greg Gould as Chief Financial Officer

HealthTech CFO with extensive public company experience building organizations for growth and value creation Demonstrated success in raising capital, driving profitability, and scaling operations to $500M revenue while ensuring compliance... Full story

Yahoo Finance • 8 months ago

Auddia Announces Non-binding Letter of Intent for Business Combination and Restructuring

Restructuring into a holding company focused on delivering AI and web3 efficiencies to portfolio companies AI efficiencies include discounted AI compute costs, centralized AI model training and engineering, and utilization of AI tools to... Full story

Yahoo Finance • 8 months ago

Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts

Nociscan YOY scan volume increased 132% from Q2 2024 to Q2 2025 fueled by new physician adoption and insurance company coverage in the UK Company has achieved two consecutive quarters of scan volume growth for the first time and expects co... Full story

Yahoo Finance • 10 months ago

Aclarion Enrolls First Patient In CLARITY Trial Evaluating Nociscan In Spine Surgery

(RTTNews) - Aclarion, Inc. (ACON), a healthcare technology firm, has announced the enrollment of the first patient in its CLARITY trial. The study aims to evaluate the clinical and economic value of its Nociscan platform in spine surgerie... Full story

Yahoo Finance • 10 months ago

Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum

BROOMFIELD, Colo., June 24, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (Aclarion or the Company) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to... Full story

Yahoo Finance • last year

Artificial Intelligence Influence on Healthcare Industry Reaching All Time Highs for Diagnostics and Treatments

PALM BEACH, Fla., March 10, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - A report from Fortune Business Insights said that the global artificial intelligence in healthcare market size is projected to grow from USD 27.69 bill... Full story

Yahoo Finance • last year

Why Is Healthcare Technology Company Aclarion Stock Rocketing Premarket On Monday?

Aclarion, Inc. (NASDAQ:ACON) shares are trading higher premarket on Monday after the company disclosed a commercial partnership with Scripps Health in San Diego, CA. This agreement will introduce Nociscan to Southern California and to the... Full story

Yahoo Finance • last year

Aclarion, Inc. Announces Adjournment of Special Meeting of Stockholders

BROOMFIELD, Colo., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc. ("Aclarion" or the "Company") (NASDAQ: ACON) (NASDAQ: ACONW),ahealthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), artificial intelligen... Full story

Yahoo Finance • 2 years ago

Aclarion Presents at the NIH HEAL Initiative Fall Meeting

The Helping to End Addiction Long-term® Initiative, or NIH HEAL Initiative®, is funding ground-breaking low back pain research. The Back Pain Consortium (BACPAC) Research Program, a recipient of the NIH HEAL Initiative, is an effort to ad... Full story

Yahoo Finance • 3 years ago

Aclarion Provides Updated Investor Presentation and Corporate Update

Aclarion is steadily executing on a proven path toward standard of care. Ten prominent Key Opinion Leader (KOL) surgeons have formally engaged to partner with the company to drive market traction and reimbursement. Company is poised to r... Full story

Yahoo Finance • 3 years ago

Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine Symposium

NociscanTM is the first evidence-supported SaaS platform to objectively measure discogenic biomarkers for insight into pathological pain. Nociscan provides decision support to help bridge a major diagnostic void. Robert Eastlack, MD will... Full story